Nakatsukasa K, Koyama H, Oouchi Y, Imanishi S, Mizuta N, Sakaguchi K, Fujita Y, Fujiwara I, Kotani T, Matsuda T, Fukuda K, Morita M, Kawakami S, Kadotani Y, Konishi E,Yanagisawa A, Taguchi
T. Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2-negative primary breast cancer. Breast Cancer. 2017 Jan;24(1):63-68.
Kiyomi Harada, Kiyo Ochi, Tetsuya Taguchi, Terukazu Nakamura, Motohiro Kanazawa, Naohisa Yoshida, Hiroko Neriya, Masami Okagaki, Naoko Nishida, Yukie Takishita, Yoko Yamamoto, Sayoei Wada,
Masashi Kawahata, Isao yokota, Kwiko Sekido, and Akane Higashi. Validity of the Short Nutritional Assessmet Questionnaire for Japanese Patients with Cancer Undergoing Outpatient Chemotye. The
Journal of Medical Investigation vol.65 No.1,2,February, 2017
Shien T, Tanaka T, Tanabe M, Okumura Y, Masuda N, Yoshida A, Arima N, Komoike Y, Tanaka S, Iwase T, Taguchi T, Nakatsukasa K, Inaji H, Ishitobi M. Evaluation of ALDH1 expression in
ipsilateral breast cancer recurrence. Oncol Lett. 2017 Mar;13(3):1071-1077
Watanabe M, Iizumi Y, Sukeno M, Iizuka-Ohashi M, Sowa Y, Sakai T. The pleiotropic regulation of cyclin D1 by newly identified sesaminol-binding protein ANT2 Oncogenesis. 2017 Apr
3;6(4):e311.
Nakatsukasa K, Koyama H, Ouchi Y, Sakaguchi K, Fujita Y, Matsuda T, Kato M, Konishi E, Taguchi T. Effect of denosumab administration on low bone mineral density (T-score -1.0 to -2.5)
in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer.J Bone Miner Metab. 2017 Nov 7. doi: 10.1007/s00774-017-0884-x. [Epub ahead of print]
Nakatsukasa K, Koyama H, Oouchi Y, Imanishi S, Mizuta N, Sakaguchi K, Fujita Y, Imai A, Okamoto A, Hamaoka A, Soushi M, Fujiwara I, Kotani T, Matsuda T,Fukuda K, Morita M, Kawakami S,
Kadotani Y, Konishi E, Yanagisawa A, Goto M, Yamada K, Taguchi T. Docetaxel, cyclophosphamide, and trastuzumab as neoadjuvant chemotherapy for HER2-positive primary breast cancer. Breast
Cancer. 2017 Jan;24(1):92-97.
Hisako Ono, Y. Iizumi, W. Goi, Y. Sowa, T. Taguchi and T. Sakai. Ribosomal protein S3 regulates XIAP expression independently of the NF-ĸB pathway in breast cancer cells. Oncology
Reports 2017;38:3205-3210
Hisako Ono, M. Tanabe, K. Kimura, Y. Miyagi, T. Iwase and S. Ohno. The management of contralateral axillary sentinel lymph nodes detected by lymphoscintigraphy in a patient of breast cancer
that had never undergone breast-related medical treatment. Clinical Investigation 2017;7:17-24
Katsuhiko Nakatsukasa, Hiroshi Koyama, Takayuki Matsuda ,Kenichirou Fukuda, Midori Morita, Makoto Kato, Kouichi Sakaguchi, Yoshifumi Fujita, Yoshimi Ouchi, Tetsuya Taguchi. Effect of
denosumab on bone mineral density (T-score classification of −1.0 to −2.5) in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer. 2017 ASCO
annual Meeeting, June 2-6,2017;CHICAGO